The objective of this study was to determine whether uterine stromal and/or epithelial progesterone receptor (PR) is required for the antagonism by progesterone (P 4 )
INTRODUCTION
Two major ovarian steroids, progesterone (P 4 ) and estradiol-17␤ (E 2 ), are key regulatory components of reproduction in females. Uterine function is coordinately regulated by P 4 and E 2 , and in many cases P 4 antagonizes the effect of E 2 . For example, in the mouse uterus, E 2 is mitogenic in vivo while P 4 inhibits E 2 -induced proliferation of endometrial epithelium [1] . P 4 also inhibits expression of E 2 -regulated genes such as Muc-1 [2] and C3 [3] in the mouse uterine epithelium. Both P 4 and E 2 elicit their functions through binding to specific intranuclear proteins-progesterone receptors (PR), and estrogen receptors (ER), respectively. Mice with targeted disruption of the PR gene (socalled PR knockout [PRKO] mice) exhibit impaired reproduction due to abnormalities in behavior, as well as abnormalities in progesterone target organs. In the uterus, the absence of PR results in epithelial hyperplasia due to the unopposed mitogenic action of E 2 [4] . 1 Supported by NIH Grants AG-13784 and DK47517, AG-15500 and HD-07857. The PR gene itself is one that is regulated by both E 2 and P 4 . In many mammalian species, PR is expressed in most major cell types of the uterus: luminal and glandular epithelium, endometrial stroma, and myometrium. In humans [5] , primates [6] , sheep [7] , cats [8] , and pigs [9] , PR is up-regulated by E 2 and down-regulated by P 4 in most uterine cells, including epithelial cells. However, PR is down-regulated by E 2 in uterine epithelium of rats and mice [10] [11] [12] [13] [14] . In the accompanying paper, we have demonstrated that E 2 down-regulates uterine epithelial PR through ER␣ in uterine stroma [15] . Thus, uterine epithelial PR is regulated by E 2 via a paracrine mechanism.
Lactoferrin is one of the major estrogen-regulated secretory proteins in the murine uterine epithelium, and its expression is induced by E 2 and inhibited by P 4 [16] . A previous study has shown that both epithelial and stromal ER␣ are essential for E 2 -induced lactoferrin expression [17] . Thus, regulation of lactoferrin by E 2 in uterine epithelium involves both direct and paracrine action of E 2 through epithelial and stromal ER␣, respectively.
The objective of this study was to determine whether P 4 elicits its effect on expression of PR and lactoferrin in uterine epithelial cells via epithelial and/or stromal PR. Both E 2 -induced down-regulation of PR and E 2 -induced up-regulation of lactoferrin require stromal ER␣. Given the importance of paracrine pathways in uterine biology, it is essential to determine whether epithelial and/or stromal PR is required for P 4 antagonism of E 2 actions on expression of PR and lactoferrin in the mouse uterine epithelium. Effects of P 4 on uterine epithelial PR in mice and rats have not been studied adequately even though P 4 has been reported to inhibit E 2 -induced down-regulation of uterine epithelial PR in rats [12] but not in mice [14] .
In this report, we demonstrate the inhibitory effect of P 4 on E 2 -induced down-regulation of mouse uterine epithelial PR. In ovariectomized mice, PR was highly expressed in uterine epithelium. E 2 down-regulated uterine epithelial PR, and P 4 partially inhibited the E 2 -induced down-regulation of PR protein and mRNA in murine uterine epithelium. Tissue recombination experiments utilizing PRKO mice demonstrated that uterine epithelial PR was regulated by P 4 through novel paracrine mechanisms mediated via stromal PR. Uterine epithelial PR itself was not sufficient to block E 2 -induced down-regulation of epithelial PR. Tissue recombination experiments also showed that P 4 can partially inhibit the E 2 -induced lactoferrin expression via stromal PR, but both epithelial and stromal PR were essential for full antagonism of P 4 on E 2 -induced lactoferrin expression. Thus, lactoferrin is regulated by P 4 through both a direct action via epithelial PR and a indirect paracrine mechanism via stromal PR.
MATERIALS AND METHODS

Animals and Treatments
All animals were maintained in accordance with the NIH Guide for Care and Use of Laboratory Animals, and all procedures described here were approved by the University of California-San Francisco and University of Illinois animal care and usage committees. Mice were maintained under controlled temperature and lighting conditions during the experiment, and were given food and water ad libitum. Adult female athymic nude mice and adult female CD-1 mice were purchased from Charles River (Wilmington, MA). PRKO mice were produced as described previously [4] .
All hormone injections were i.p. in 0.1 ml peanut oil (Sigma, St. Louis, MO). To study the effect of P 4 on expression of PR and lactoferrin, hormone treatments were adapted from previous studies [2, [15] [16] [17] with modifications. Daily dosages of 125 ng E 2 (Sigma) and 2 mg progesterone (Steroids Inc., Wilton, NH) were used. In all experiments, hormone treatment was started 2 wk after ovariectomy. Ovariectomized female CD-1 mice (approximately 90 days old) and host athymic nude mice for PRKO/wildtype (wt) uterine tissue recombinants received hormone treatments on the following schedule: oil group, oil only on Days 1-4; E 2 group, oil on Day 1, E 2 on Days 2-4; E 2 ϩP 4 group, P 4 on Day 1, E 2 ϩP 4 on Days 2-4; P 4 group, P 4 on Days 1-4. Twenty-four hours after the last hormone injection, animals were killed to harvest tissue samples. In the tissue recombinant experiments, vaginae and uteri were also collected from host mice as controls.
Tissue Separation, Recombination, and Grafting
Procedures for separation and recombination of epithelium and stroma from mouse uteri have been described previously [18] . Details of uterine tissue recombination with PRKO mice have been described previously [19] . Briefly, uteri from PRKO or wt litter mates were dissected free of adherent connective tissue and fat, placed into Hanks' Balanced Salt Solution (HBSS), and cut into 4-6 segments/ uterine horn. The pieces were enzymatically dissociated by placing them in a solution of 1% trypsin 1/250 (Difco Laboratories, Detroit, MI) in calcium-and magnesium-free HBSS for 90 min at 4ЊC. After trypsin digestion, uterine segments were opened longitudinally with spring-loaded Vannas scissors, and then stroma and epithelium were physically separated using fine surgical instruments. Stroma and epithelium were recombined on nutrient agar plates and allowed to adhere during overnight culture at 37ЊC. After overnight culture, the tissue recombinants were grafted under the renal capsules of female athymic nude mice. Approximately 1 mo after grafting, all hosts were ovariectomized and then received the hormone treatments described above.
Immunohistochemistry
Anti-human PR rabbit polyclonal IgG and anti-human ER␣ mouse monoclonal IgG 1D5 were purchased from DAKO (Carpenteria, CA). Rabbit antiserum against lactoferrin was obtained from Dr. Christina Teng (National Institute of Environmental Health Science, Research Triangle Park, NC). Tissues were fixed with 4% paraformaldehyde for 3 h on ice, processed into paraffin, and then sectioned at 6 m. Immunohistochemical detection of ER␣ [20] and PR [19] in mouse tissues has been described. Immunoreactivity was developed for ER␣ and PR by a Vectastain Elite ABC kit (Vector Laboratories Inc., Burlingame, CA). For lactoferrin immunohistochemistry, tissue sections were deparaffinized through series of xylene and ethanol, and then sections were incubated overnight with lactoferrin antiserum (1:200 in PBS) or nonimmune normal rabbit serum (Zymed Laboratories, Inc., South San Francisco, CA). Sections were then incubated with fluorescein isothiocyanate (FITC)-conjugated anti-rabbit IgG (Sigma), and the lactoferrin immunoreactivity was visualized by fluorescent microscopy. No signal was observed in the negative control with nonimmune rabbit serum (data not shown).
Image Analysis
Morphometric analysis of PR immunohistochemistry has been described [15] . For morphometric analysis of PR immunohistochemistry, epithelial nuclei were manually picked up by adjusting the threshold from immunostained slides, and then the optical density (OD) in the yellow channel of the CMYK (cyan, magenta, yellow, black) mode was measured in the epithelial nuclei. The average OD of controls with nonimmune IgG was used as the baseline (OD ϭ 0). In each group, approximately 5000 nuclei were analyzed from 5 to 8 samples. For morphometric analysis of lactoferrin immunohistochemistry, fluorescent images of lactoferrin immunohistochemistry were captured with a DC330 camera (Dage-MTI Inc., Michigan City, IN) interfaced with a PowerBase 200 computer (Power Computing, Round Rock, TX) and analyzed with Scion Image 1.62a (Scion Inc., Frederick, MD). Areas of epithelia were manually selected from the brightfield images, and the OD of the FITC images was measured in the selected area. In each group, approximately 1000 cells were analyzed from 4 to 8 tissue recombinants of 3-5 independent experiments. Statistical analysis was performed using the StatView software (Abacus Concepts Inc., Berkeley, CA). To compare OD for different hormone treatments, ANOVA was used. To compare OD for different tissue types and hormone treatments, two-factorial ANOVA was used. In both cases, Fisher's protected least-significant-difference (PLSD) test was used for follow-up analysis to determine difference between groups (P Ͻ 0.01). In total, the quantitative immunohistochemical studies are based upon the analysis of 38 tissue recombinants and 23 uteri for PR, and 96 tissue recombinants for lactoferrin.
Preparation of Total RNA
Adult (approximately 90-day-old) female CD-1 mice were ovariectomized. Two weeks later, mice were given hormones as described above. All mice were killed 24 h after the last injection, and uteri were removed. Epithelium and stroma were separated as described above, and then the epithelium was flash-frozen in liquid N 2 . Uteri from at least 2 mice were used for each treatment group in each experiment, and the entire experiment was repeated 3 times. Total RNA was prepared from frozen uterine and vaginal epithelial tissue by rapidly homogenizing the tissue in a guanidine isothiocyanate solution with a Polytron homogenizer (Brinkman Instruments, Westbury, NY). Total RNA was then isolated using the RNeasy Mini Kit (Qiagen, Chatsworth, CA). Purified total RNA was dissolved in diethylpyrocarbonate-treated water. Purity and concentration of the RNA was determined by UV (260/280) absorbance in a spectrophotometer.
Northern Blotting
For all Northern blots, equal amounts of uterine epithelial RNA from oil-, E 2 -, and E 2 ϩP 4 -treated mice were electrophoresed on 1.5% agarose formaldehyde gels. The gels were blotted to nylon membranes, and the RNA was fixed to the membrane by UV cross-linking. The following cDNA probes were used in this study: 1) murine PR [21] , a gift from Dr. G. Shyamala, Lawrence Berkeley Laboratory, Berkeley, CA, and 2) human 28S rRNA [22] . A fragment for the PR cDNA probe was isolated from the plasmid vector by restriction digestion and gel purification. Each fragment was labeled with 32 P-dCTP using the multiprime DNA labeling system (Amersham, Arlington Heights, IL) and was used to probe the membrane.
All hybridizations were carried out in QuickHyb (Stratagene, La Jolla, CA) at 68ЊC. The hybridized membrane was washed, covered with plastic wrap, and exposed to Kodak X-omat x-ray film (Eastman Kodak, Rochester, NY) with intensifying screens. After hybridization with the PR cDNA probe, membranes were stripped of probe by incubation in 50% formamide at 65ЊC for 1 h; then the membrane was reprobed with labeled 28S rRNA cDNA probe, as described previously [23] .
The mRNA transcript bands on the autoradiographs were scanned and quantitated using a computer-linked scanning laser densitometer and RFLPrint software (Pdi, Huntington Station, NY). The strongest band (the 6.9-kilobase [kb] band) for PR mRNA and the band for 28S rRNA were scanned, and the ratio of intensity of the 6.9-kb band to that of the 28S band (6.9 kb:28S) was calculated in each lane. In each blot, the ratio of 6.9 kb:28S in the oil-treated group was considered 100%. The data was analyzed by ANOVA and Fisher's PLSD tests in the InStat statistical package (GraphPad Software Inc., San Diego, CA).
RESULTS
Regulation of PR by E 2 and P 4 in Uterine Epithelium
To study the effects of E 2 and P 4 on expression of PR in the uterus, mature wt female mice were ovariectomized, and 2 wk after ovariectomy all animals received injections of oil only, or E 2 and/or P 4 . In all hormone treatment groups, ER␣ was detectable by immunohistochemistry in endometrial stroma, myometrium, luminal, and glandular epithelium (Fig. 1, a, c, e, and g ). In the uterus of ovariectomized oil-treated mice, both intensity of PR immunostaining and the number of PRpositive cells were low in the peripheral endometrial stroma and myometrium, but PR was strongly expressed in subepithelial endometrial stroma and in luminal and glandular uterine epithelium (Fig. 1b) . E 2 induced PR expression throughout the endometrial stroma and in the myometrium, while simultaneously down-regulating PR in the uterine epithelium (Fig. 1d) . Pretreatment with P 4 plus coadministration of P 4 with E 2 inhibited this down-regulation of epithelial PR induced by E 2 (Fig. 1f) . In E 2 ϩP 4 -treated mice, both the percentage of PR-positive cells and PR signal intensity in uterine epithelium were higher than those in E 2 -treated mice (Fig. 1, d and f) . Although E 2 -induced downregulation of uterine epithelial PR was inhibited by P 4 , pretreatment and coadministration of P 4 did not block E 2 -induced PR in endometrial stroma and myometrium of E 2 ϩP 4 -treated mice (Fig. 1f) . P 4 alone had very little effect on uterine PR expression. Thus, in the P 4 -treated mice, the PR localization was very similar to that of oil-treated mice even though the PR immunostaining was slightly stronger than that of the oil-treated group in the subepithelial endometrial stroma (Fig. 1 h) .
The effect of E 2 and P 4 on PR mRNA was analyzed by Northern blot in uterine epithelium (Fig. 2) , and the results confirmed those of immunohistochemical studies. Uterine epithelial PR mRNA level was high in oil-treated mice and low in E 2 -treated mice. The PR mRNA level in uterine epithelium of E 2 ϩP 4 -treated mice was intermediate between that of oil-and E 2 -treated mice.
The relative PR expression level in uterine epithelium was determined by measuring optical density of epithelial nuclei in PR immunostained sections. Morphometric analysis of PR expression in uterine epithelium showed clear differences among the hormone treatment groups (Fig. 2B,  IHC) . PR expression in uterine epithelium was significantly higher in the oil-treated group than in either the E 2 group or the E 2 ϩP 4 group (P Ͻ 0.01), and was significantly higher in E 2 ϩP 4 group than in the E 2 group (P Ͻ 0.01). Normalized densitometric data for uterine epithelial PR mRNA level was obtained by quantitating expression of the most abundant 6.9-kb PR transcript (Fig. 2B, Northern) . PR mRNA expression in uterine epithelium in the oil-treated group, which was normalized to 100%, was high, and decreased to 25% in the E 2 -treated group. The reduction in uterine epithelial PR elicited by E 2 was partially antagonized by P, as shown by the smaller decrease in the 6.9-kb PR mRNA band in the E 2 ϩP 4 group compared to that in the group receiving E 2 alone.
Role of Stromal PR in the Inhibitory Effect of P 4 on E 2 -Induced Down-Regulation of Uterine Epithelial PR
Since PR is expressed in both uterine epithelium and stroma, we examined whether stromal PR was required to mediate the inhibitory effect of P 4 on E 2 -induced downregulation of uterine epithelial PR. Two types of uterine tissue recombinants were prepared with uterine epithelium (E) and stroma (S) from wt or PRKO mice: wt-Sϩwt-E and PRKO-Sϩwt-E. In the oil-treated (Fig. 3A, a and d ) and E 2 -treated (Fig. 3A, b and e) groups, epithelial PR expression was essentially the same as that of host uterine tissue in both wt-Sϩwt-E and PRKO-Sϩwt-E tissue recombinants: epithelial PR was high in the oil-treated group and dramatically reduced in the E 2 -treated group. In contrast, P 4 inhibition of E 2 -induced down-regulation of epithelial PR was observed only in wt-Sϩwt-E tissue recombinants. With E 2 ϩP 4 , epithelial PR was strongly expressed in wtSϩwt-E tissue recombinants (Fig. 3A, c) indicating that the P 4 had inhibited E 2 -induced down-regulation of uterine epithelial PR. In contrast, PR was almost undetectable in PRKO-Sϩwt-E tissue recombinants treated with E 2 ϩP 4 (Fig. 3A , f) indicating that P 4 had not inhibited E 2 -induced down-regulation of uterine epithelial PR. There was no observable difference in PR level between glandular and luminal epithelia (data not shown).
To show the change in epithelial PR level among different hormone treatment groups more clearly, the relative epithelial PR levels in uterine tissue recombinants were determined by measuring OD of epithelial nuclei in PR immunostained sections (Fig. 3B) . In both wt-Sϩwt-E and PRKO-Sϩwt-E tissue recombinants, epithelial PR level was significantly higher in the oil-treated group than in the E 2 -treated and E 2 ϩP 4 -treated groups (P Ͻ 0.01). In tissue recombinants composed with wt-S (wt-Sϩwt-E), epithelial PR level was significantly higher in the E 2 ϩP 4 group than FIG. 3 . PR immunostaining in PRKO/wt uterine tissue recombinants. A) PR immunohistochemistry. Tissue recombinants were made with wt epithelium (wt-E) and wt stroma (wt-S) (a-c) or wt-E and PRKO stroma (ko-S) (d-f ). Tissue recombinants were grafted under the renal capsule of female nude mouse hosts and grown for approximately a month; then all hosts were ovariectomized. Two weeks after ovariectomy, all hosts received hormone treatments as described in Materials and Methods. ko-S, PRKO-S. B) Epithelial PR level in PRKO/wt uterine tissue recombinants. Data are mean Ϯ SEM of values and were statistically analyzed by two-factorial AN-OVA and Fisher's PLSD (P Ͻ 0.01).
in the E 2 group, indicating that P 4 was effective in partially inhibiting E 2 -induced down-regulation of uterine epithelial PR. In contrast, there was no significant difference in the epithelial PR level between E 2 and E 2 ϩP 4 groups (P Ͻ 0.01) in PRKO-Sϩwt-E tissue recombinants, indicating that P 4 was not effective in inhibiting E 2 -induced down-regulation of uterine epithelial PR. This result clearly demonstrates that P 4 action on uterine epithelial PR expression requires stromal PR. Uterine epithelial PR is not sufficient to block E 2 action on uterine epithelial PR expression.
Roles of Epithelial and Stromal PR in the Inhibitory Effect of P 4 on E 2 -Induced Lactoferrin Expression
To study the respective roles of epithelial and stromal PR in the P 4 inhibitory effect on E 2 -induced lactoferrin expression, 4 types of tissue recombinants were prepared (wt-Sϩwt-E, wt-SϩPRKO-E, PRKO-Sϩwt-E, and PRKO-SϩPRKO-E). In all 4 types of tissue recombinants, lactoferrin was undetectable in the oil-treated group (Fig. 4A, a) and was dramatically induced in the E 2 -treated group (Fig.  4A, b) . In all 4 types of tissue recombinants, lactoferrin staining was significantly higher in the E 2 -treated group than in the oil groups (P Ͻ 0.01; Fig. 4B ). In addition, there were no significant differences (P Ͻ 0.01) in lactoferrin levels between the 4 types of tissue recombinants within the oil-treated group (Fig. 4B, columns with *) or the E 2 -treated groups. In wt-Sϩwt-E tissue recombinants, P 4 completely inhibited E 2 -induced lactoferrin, and lactoferrin was undetectable (Fig. 4A, c) . In wt-Sϩwt-E tissue recombinants, the lactoferrin level were identical for E 2 ϩP 4 -treated and oil-treated groups (Fig. 4B) . In wt-SϩPRKO-E tissue recombinants, P 4 significantly reduced the level of E 2 -induced lactoferrin, but lactoferrin was still strongly detected, especially on apical side of the cytoplasm FIG. 4 . Lactoferrin immunostaining in PRKO/wt uterine tissue recombinants. Tissue recombinants were made with uterine E and S from wt and/or PRKO mice and were grafted under the renal capsule of female nude mice and grown for approximately a month. All hosts were then ovariectomized. Two weeks after ovariectomy, all hosts received daily injection of oil, E 2 or E 2 ϩP 4 as described in Materials and Methods. A) Lactoferrin immunohistochemistry. FITC images were reversed, then superimposed on the brightfield image. B) Lactoferrin levels in PRKO/wt uterine tissue recombinants. Data are mean Ϯ SEM of values. Data were statistically analyzed by two factorial-ANOVA and Fisher's PLSD. Columns without *, significantly higher than those with * and ** (P Ͻ 0.01). **Significantly higher than * (P Ͻ 0.05). (Fig. 4A, d) . The lactoferrin levels in wt-SϩPRKO-E tissue recombinants were significantly higher in the E 2 ϩP 4 -treated group (Fig. 4B , a, column with **) than in the oil-treated group (P Ͻ 0.05), indicating that P 4 partially inhibited E 2 action. In contrast, in PRKO-Sϩwt-E (Fig. 4A, e) and PRKO-SϩPRKO-E tissue recombinants (Fig. 4A, f) , P 4 did not down-regulate E 2 -induced lactoferrin expression, and lactoferrin levels in the E 2 ϩP 4 -treated group was identical to that of the E 2 -treated group (P Ͻ 0.01; Fig. 4B) . These results clearly demonstrate that P 4 inhibition of lactoferrin expression requires both epithelial and stromal PR. Uterine epithelial or stromal PR alone is not sufficient to block E 2 -induced lactoferrin expression.
DISCUSSION
In this study, we have shown for the first time that P 4 inhibits E 2 -induced down-regulation of murine uterine epithelial PR in vivo, and that uterine stromal PR is essential for P 4 to antagonize E 2 -induced down-regulation of epithelial PR. Our previous tissue recombinant studies using ER␣ knockout mice demonstrated that uterine epithelial PR is down-regulated by E 2 through a paracrine mechanism mediated via stromal ER␣ [15] . Thus, the actions of both E 2 and P 4 on uterine epithelial PR involve paracrine mechanisms mediated by their respective steroid receptors in mouse uterine stroma. In both cases, epithelial ER␣ and PR are not sufficient to regulate mouse uterine epithelial PR in vivo. In a previous study, we demonstrated that epithelial ER␣ is likewise not required for E 2 -induced down-regulation of uterine epithelial PR [15] . Since expression of epithelial PR is the endpoint of the present study, we could not use PRKO mice to test whether epithelial PR is required for the inhibitory effect of P 4 on E 2 -induced down-regulation of uterine epithelial PR. Nonetheless, analysis of the PRKO-Sϩwt-E tissue recombinant clearly shows for the first time that epithelial PR is not sufficient by itself to antagonize E 2 -induced down-regulation of uterine epithelial PR. Epithelial PR still may play some role because the binding of P 4 to the epithelial PR may affect stability of the PR protein.
In the previous report, we demonstrated that E 2 acts in vivo on murine uterine stroma to down-regulate uterine epithelial PR via paracrine mechanisms [15] . Many in vitro studies have shown that ER␣ and PR interact directly, and that occupied PR can act to repress transcription activity of ER␣ [24] [25] [26] [27] . Given the scenario that E 2 down-regulates uterine epithelial PR via stromal ER␣ and that P 4 inhibits E 2 -induced down-regulation of epithelial PR through signals mediated via stromal PR, the inhibitory effect of P 4 on E 2 -induced down-regulation of uterine epithelial PR could result from impaired synthesis of E 2 -induced paracrine factors. Alternatively, P 4 itself may independently induce paracrine factors that antagonize the action of E 2 -induced paracrine mediators.
With regard to regulation of lactoferrin, our tissue recombination study clearly showed that the full inhibition by P 4 of E 2 -induced lactoferrin expression requires both epithelial and stromal PR. It has been believed that the PR level is critical in determining responsiveness of cells to P. Even though epithelial cells were derived from wild-type mice, epithelial PR level, and thus sensitivity of the entire tissue recombinant to P, should be exceedingly low in PRKOSϩwt-E tissue recombinants of the E 2 ϩP 4 -treated group, because P 4 cannot oppose the action of E 2 to down-regulate uterine epithelial PR because of an absence of stromal PR. This may explain why P 4 did not inhibit E 2 -induced lactoferrin expression in PRKO-Sϩwt-E tissue recombinants. We also demonstrated that P 4 can partially inhibit lactoferrin expression via stromal PR in wt-SϩPRKO-E tissue recombinants. This result suggests the involvement of a paracrine mechanism in P 4 regulation of lactoferrin expression, and agrees with our recent finding that both stromal and epithelial ER␣ are essential for induction of lactoferrin in the uterine epithelium by E 2 [17] . We speculate that P 4 acting through stromal PR inhibits lactoferrin expression by antagonizing E 2 -induced stromal signals, which are essential for lactoferrin expression in uterine epithelium.
Hormone target organs such as the uterus and vagina express ER␣ and PR in both epithelial and stromal cells. Recent studies using tissue recombinants composed of wild-type plus ER␣ knockout or wild-type plus PRKO epithelium and stroma are instrumental in defining the respective role of epithelial versus stromal ER␣ and PR in hormonal response. Through such studies, we have shown that E 2 -induced growth (DNA synthesis) of uterine, vaginal, and mammary epithelia is mediated through stromal ER␣ [20, 28, 29] . P 4 inhibition of E 2 -induced uterine epithelial proliferation is likewise mediated through stromal PR [19] . Thus, in the mouse uterus, E 2 and P 4 regulate both epithelial proliferation and epithelial PR through paracrine mechanisms. These facts suggest the possibility that uterine epithelial PR expression is regulated through the cell cycle. However, a single injection of 125 ng E 2 induces uterine epithelial proliferation but does not down-regulate uterine epithelial PR when assayed 18 h after hormone treatment [19] . Thus, uterine epithelial PR is probably not regulated by E 2 and P 4 through the cell cycle.
Regulation of murine uterine epithelial cell proliferation in vivo by E 2 and P 4 requires receptors in uterine stroma only and not in the epithelium. On the other hand, recent tissue recombinant studies showed that both stromal and epithelial ER␣ are essential for E 2 -induced cornification in vagina [28] and E 2 induction of lactoferrin and C3 expression in uterus [17] . A role of epithelial PR in the regulation of lactoferrin by P 4 in the mouse uterus was defined for the first time in this study by demonstrating that full inhibition of lactoferrin requires both epithelial and stromal PR. Further tissue recombination studies with PRKO and wt mice should define the respective functions of uterine epithelial and stromal PR in other actions of P 4 in vivo. We emphasize that stromal PR should be required for most uterine epithelial functions that are regulated by a combination of E 2 plus P 4 since P 4 modulates uterine epithelial levels of PR via stromal PR.
